UnitedHealth Group covers Guardant Health Shield blood test for colorectal cancer screening

Guardant Health
UnitedHealth Group Incorporated

Guardant Health

GH

0.00

UnitedHealth Group Incorporated

UNH

0.00
  • UnitedHealth Group began covering Guardant Health’s FDA-approved Shield blood test for colorectal cancer screening for eligible members.
  • Policy expands access for average-risk adults aged 45 or older across commercial, employer, individual, Medicare Advantage, and Medicare supplemental plans.
  • Coverage adds about 40 million potential members, lifting Shield’s total access footprint to 100 million covered lives.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Guardant Health Inc. published the original content used to generate this news brief on July 01, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.